Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: Two China Biopharmas Raise $1.4 Billion in Hong Kong IPOs
Week in Review: China Pharmas Announce Deals Worth $1.5 Billion
Week in Review: BeiGene Forges $1.3 Billion Bi-Specific Antibody Deal with Zymeworks
Week in Review: Alphamab Closes $100 Million Series A for Oncology Candidates
Week in Review: bioMérieux Acquires Majority Stake in China Diagnostics Company for $114 Million
Upcoming event
San Francisco, USA
January 6, 2019
Use 'ChinaBio200' to get a USD200 Discount!
Shanghai , China
May 8-9, 2019
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China